Is bemotrizinol safe?
Bemotrizinol is considered safe for use in sunscreens by Health Canada, European and other regulators, and as of 2026 the US FDA as well, including for children 6 months and older.
It has been used in sunscreens in Canada, Europe and elsewhere for years, and reviews of global safety databases found no confirmed serious adverse events linked to it.
Good
Based on regulatory safety reviews and pharmacokinetic/toxicology studies submitted to agencies, not a randomized controlled trial testing health outcomes, but consistent across multiple independent regulators.
What the evidence says
Bemotrizinol is a sunscreen ingredient that blocks both UVA and UVB rays. It's already approved for use in Canada, where Health Canada lists it in the Primary Sunscreen Monograph at concentrations up to 6%. It's also been used safely in European and other sunscreens for many years.
In the United States, the FDA only recently added bemotrizinol to its approved sunscreen ingredient list, treating it as generally recognized as safe and effective for adults and children 6 months of age and older. FDA reviewers looked at global safety monitoring data, including from Health Canada, and found no confirmed serious adverse events tied to the ingredient. Studies measuring how much bemotrizinol gets absorbed into the bloodstream after sunscreen use found levels were low, and side effects reported in clinical studies were mostly mild, such as skin irritation.
Animal reproductive and developmental studies did not turn up concerning effects either. For a young child, using a sunscreen containing bemotrizinol as directed is considered reasonable by regulators, though as with any sunscreen it's sensible to avoid use on broken skin, keep it out of eyes, and follow age directions on the label (many products advise checking with a doctor for infants under 6 months).
Sources
-
Guideline
Bemotrizinol - NHPID ingredient entry
Health Canada
Lists bemotrizinol as approved in Canada's Primary Sunscreen Monograph.
-
Guideline
Sunscreens
Canada.ca / Health Canada
Canadian regulatory framework and general sunscreen safety guidance.
-
Guideline
FDA Expands Sunscreen Options for the First Time in 20 Years
U.S. FDA
FDA final order: bemotrizinol GRASE for ages 6 months and up.
-
Guideline
FDA Proposes Expanding Sunscreen Active Ingredient List
U.S. FDA
Background on FDA's review process before final approval.
-
Guideline
Safety Summary for Bemotrizinol (BEMT), cover letter to FDA
U.S. FDA (accessdata.fda.gov)
Reviews global pharmacovigilance including Health Canada data; no serious adverse events found.
✓Reviewed by CH, MD, FRCPC
Reviewed by a specialist physician certified by the Royal College of Physicians and Surgeons of Canada, who has read this answer against the sources listed above and confirmed it reflects them. That is not medical advice about your child. How we review
Answer checked August 2, 2026